Study Details

General Information

Redhill H.Pylori-Central Location

A Randomized, Placebo-Controlled, Phase III Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobactor pyori (H. Pylori) Infection in Non--Investigated Dyspepsia Patients.

Protocol
IdentifierRHB-105-01 Site Number
UIDb027a8d9-7c17-4460-90a9-0ba978b1ca50
StatusCancelled
Phase3
CategoryH. pylori
Launch Year0
NCT Number-
Created2015-03-18 16:06
Last Updated2015-03-18 16:06

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMoon, MiaMMoonNo
Recruiter-No
Coordinator-No
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorRedhill Biopharma Ltd
DivisionRedhill Biopharma Ltd
TeamRedhill Biopharma Ltd
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROClinipace, Inc
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorYellow
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?